The Potential for Increasing Risk of Consent Refusal in COVID-19 Trials: Considering Underlying Reasons and Responses
Ann Am Thorac Soc
.
2022 Sep;19(9):1446-1447.
doi: 10.1513/AnnalsATS.202203-250VP.
Authors
James A Russell
1
2
,
Keith R Walley
1
2
,
Andre C Kalil
3
,
Robert Fowler
4
Affiliations
1
Centre for Heart Lung Innovation and.
2
Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
3
University of Nebraska Medical Center, Omaha, Nebraska; and.
4
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
PMID:
35486858
PMCID:
PMC9447399
DOI:
10.1513/AnnalsATS.202203-250VP
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Informed Consent
Grants and funding
CIHR RN420682 - 439993/CIHR/Canada
CIHR RN423207 - 442999/CIHR/Canada
FDN 154311/CIHR/Canada